The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering glucose levels and body weight.At the Cardiometabolic Health Congress in ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

The president-elect might bring back efforts to make other countries pay more for drugs, but there are pitfalls.

Browse in-depth TOC on " Global Biotechnology industry Outlook " 10 - Tables 20 - Figures 70 - Pages . The Global Biotech ...

Chesapeake Regional Healthcare in Virginia was indicted for healthcare fraud involving unnecessary surgical procedures.

ByReuters • Dec 23, 2024 Eli Lilly & Co. commends ITC ruling cracking down on the unlawful importation and sale of knock-off tirzepatide ... Lilly's weight-loss treatment Zepbound becomes ...

The firm said it struck a three-year licensing deal with a top pharmaceutical company that will use the data to advance GLP-1 receptor agonist research.

Clarivate identifies eleven potential blockbuster and transformative drugs in annual Drugs to Watch report: London, UK Friday, January 10, 2025, 14:00 Hrs [IST] Clarivate Plc, a l ...

How about elderberry juice? Elderberry juice might help people lose weight and improve their blood sugar control, a new small ...